600521-基本财务实时评分详情
华海药业600521基本财务实时评分详情
更新时间:2021-05-10 00:00:01
股票代码
600521
当期评分
股票名称
华海药业
报告日期2016-12-312017-12-312018-12-312019-12-312020-09-302020-09-30
每股经营现金流(¥)0.41520.5240.05431.32640.8032
销售净利润率(%)11.163312.46682.647911.262318.212
销售毛利率(%)48.86254.743158.601559.466362.7355
净资产收益率(%)11.4313.092.6410.1513.6
营业增长率(%)16.926622.21311.85115.76121.4134
净利润增长率(%)4.620436.4825-78.367349.829963.4629
每股收益(%)0.490.620.090.450.58
现金流量比率(%)28.611219.26721.424552.247629.155
三项费用比重(%)35.823940.282345.300137.793233.5602
每股净资产(¥)4.20264.68323.25364.24214.2501
流动比率(%)2.31971.43641.09361.56891.4285
速动比率(%)1.44090.87420.63520.90850.8343
现金比率(%)52.293424.384519.109644.815744.8157
总资产利润率(%)7.46458.31831.44795.75287.8274
主营利润比重%352.6656351.39711898.6738421.1137285.8194
应收账款(万元)128,091.65160,422.90189,434.97128,911.44163,383.21
应收票据(万元)2,589.725,284.594,203.48----
预付款项(万元)3,570.477,640.925,882.294,616.116,836.89
存货(万元)133,023.19159,383.52218,480.54221,702.61238,074.05
在建工程(万元)69,587.9970,491.2781,181.0092,985.29129,934.15
应付款项(万元)36,331.1738,984.3342,830.5537,652.5938,962.47
长期借款(万元)53,468.5022,216.2990,000.00117,919.32113,380.91
未分配利润(万元)182,130.02220,980.99209,159.09259,119.07316,725.05
商誉(万元)7,090.227,090.227,090.227,090.227,090.22
流动资产(万元)321,502.96419,463.27515,503.56546,265.30621,150.54
流动负债(万元)151,374.26283,508.90476,626.14335,698.93400,710.66
华海药业600521评分结果
72.73分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006